MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors
Authors:
Open Access
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 25 (3) , 378-387
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- MYC regulation of a “poor-prognosis” metastatic cancer cell stateProceedings of the National Academy of Sciences, 2010
- Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastasesBreast Cancer Research and Treatment, 2009
- Tumor Self-Seeding by Circulating Cancer CellsCell, 2009
- Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the “Basal” Breast Cancer SubgroupPLOS ONE, 2009
- MYC in breast tumor progressionExpert Review of Anticancer Therapy, 2008
- Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesisLaboratory Investigation, 2008
- Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal MetastasesClinical Cancer Research, 2008
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic miceOncogene, 1997
- Evaluation ofMYC and chromosome 8 copy number in breast carcinoma by interphase cytogeneticsGenes, Chromosomes and Cancer, 1997